Carlos King Ho Wong
Overview
Explore the profile of Carlos King Ho Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
1572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wu Y, Cheung Y, Lee J, Wong C, Ho S, Li W, et al.
J Med Internet Res
. 2024 May;
26:e44973.
PMID: 38739429
Background: While text messaging has proven effective for smoking cessation (SC), engagement in the intervention remains suboptimal. Objective: This study aims to evaluate whether using more interactive and adaptive instant...
12.
Li W, Lam D, Sin K, Wong E, Wong C, Loong H, et al.
Addiction
. 2024 May;
119(8):1468-1477.
PMID: 38708618
Background And Aims: Despite evidence that patients living with cancer who continue to smoke after diagnosis are at higher risk for all-cause mortality and reduced treatment efficacy, many cancer patients...
13.
Cheng F, Yan V, Wan E, Chui C, Lai F, Wong C, et al.
Kidney Int Rep
. 2024 May;
9(5):1244-1253.
PMID: 38707795
Introduction: Even with effective vaccines, patients with CKD have a higher risk of hospitalization and death subsequent to COVID-19 infection than those without CKD. Molnupiravir and nirmatrelvir-ritonavir have been approved...
14.
Lui D, Xiong X, Cheung C, Lai F, Li X, Wan E, et al.
Endocr Pract
. 2024 Mar;
30(6):528-536.
PMID: 38552902
Objective: The evidence of thyroid dysfunction in the post-acute phase of SARS-CoV-2 infection is limited. This study aimed to evaluate the risk of incident thyroid dysfunction in the post-acute phase...
15.
Lu F, Wong C, Ng A, Li L, Fong D, Ip P, et al.
Patient Educ Couns
. 2024 Mar;
124:108240.
PMID: 38547639
Objective: This study aimed to evaluate the effectiveness of a health empowerment programme (HEP) to enhance cardiovascular health for adults from low-income families. Methods: A prospective cohort study (N = ...
16.
Lai F, Yan V, Wan E, Chan C, Wei C, Cheng F, et al.
iScience
. 2024 Mar;
27(4):109428.
PMID: 38544567
Multimorbidity entails a higher risk of SARS-CoV-2 infection and COVID-19 complications. We examined vaccine effectiveness (VE) stratified by multimorbidity using a case-control study of territory-wide electronic health records in Hong...
17.
Mak L, Chung M, Li X, Lai F, Wan E, Chui C, et al.
World J Hepatol
. 2024 Mar;
16(2):211-228.
PMID: 38495273
Background: Chronic liver disease (CLD) was associated with adverse clinical outcomes among people with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Aim: To determine the effects of SARS-CoV-2 infection...
18.
Lam I, Zhang R, Man K, Wong C, Chui C, Lai F, et al.
Nat Commun
. 2024 Feb;
15(1):1716.
PMID: 38403654
The persisting risk of long-term health consequences of SARS-CoV-2 infection and the protection against such risk conferred by COVID-19 vaccination remains unclear. Here we conducted a retrospective territory-wide cohort study...
19.
Fan M, Peng K, Zhang Y, Lai F, Chui C, Wan E, et al.
NPJ Vaccines
. 2024 Feb;
9(1):31.
PMID: 38355656
Previous studies indicate an increased carditis risk among adolescents following the two-dose messenger RNA COVID-19 vaccine. Several jurisdictions have extended the interdose interval between the first and second doses to...
20.
Cheng F, Yan V, Wan E, Chui C, Lai F, Wong C, et al.
Clin J Am Soc Nephrol
. 2023 Dec;
19(4):418-428.
PMID: 38147590
Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed increased risks of hospitalization and mortality in patients with underlying CKD. Current data on vaccine effectiveness of COVID-19 vaccines are...